This proceedings volume results from the NATO Advanced Research Workshop on 'Biomarkers of Radiation in the Environment: Robust Tools for Risk Assessment (BRITE)'. The BRITE workshop discussed insights from cancer research, epigenetics, non-human and human risk assessment, since many of the state-of-the-art biomarkers being developed for humans deserve consideration for environmental applications and vice versa. Sessions were very wide-ranging covering methods, mechanisms, cross disciplinary application and regulation.

TECHNIQUES FOR BIOMARKER DEVELOPMENT.- Chapter 1. Reducing Uncertainties In Live Monitoring Of Radiation In Wildlife.- Chapter 2. Synchrotron Light Facilities And Applications In Life Sciences.- Chapter 3. Elemental Imaging In Biology Using Synchrotron X-Ray Fluorescence Microscopy.- LOW-DOSE EFFECT MECHANISMS Chapter 4. Modelling Direct And Indirect Effects Of Radiation: Experimental, Clinical And Environmental Implications.- Chapter 5. Immune Networks In The Context Of Low Dose Ionizing Radiation.- Chapter 6. Learning From Nato Biomarker Research For Humans.- BIOMARKERS FOR RISK EVALUATION.- Chapter 7. Exosomes As Radiation Biomarkers.- Chapter 8. Monitoring Very Low Dose Radiation Damage In Dna Using "Field-Friendly" Biomarkers.- Chapter 9. The Development Of Bio-Assays Based On Non-Targeted Effects Of Radiation; A Potential Worm-Hole Into Ecosystem Level Biomarkers.- BIOMARKERS IN WILDLIFE Chapter 10. Birds As Bioindicators Of Radioactive Contamination And Its Effects.- Chapter 11. Amphibians In Field Radioecology: A Review And Perspective.- Chapter 12. Measuring Adaptive Responses Following Chronic And Low Dose Exposure In Amphibians.- Chapter 13. Are There Ecosystem-Relevant Endpoints For Measuring Radiation Impacts?.-Chapter 14. Biomarkers And Ecological Indicators For Environmental Radioactivity In Invertebrates.-BIOMARKER USE AND RESPONSES.- Environment, Workers And Public.- Chapter 16. Application Of The International System Of Radiation Protection In Fit-For-Purpose Assessment Of Impacts.- Chapter 17. Practicalities Of Mainstreaming Biomarker Use - A Canadian Perspective.- Index.